SPDR S&P Pharmaceuticals ETF
XPH
XPH
80 hedge funds and large institutions have $185M invested in SPDR S&P Pharmaceuticals ETF in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 21 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 21
Holders
80
Holding in Top 10
–
Calls
$981K
Puts
–
Top Buyers
| 1 | +$53.7M | |
| 2 | +$6.24M | |
| 3 | +$2.3M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.49M |
| 5 |
Jane Street
New York
|
+$1.32M |
Top Sellers
| 1 | -$7.62M | |
| 2 | -$5.74M | |
| 3 | -$5.63M | |
| 4 |
Morgan Stanley
New York
|
-$5.25M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$3.96M |